AZD8630/AMG 104, an inhaled anti-thymic stromal lymphopoietin antibody fragment, for moderate-to-severe asthma: Phase 1 randomized controlled trial. - Doffman SR; Dosanjh DPS; Sadiq MW; Matsunaga Y; Cooper JD; Edwards G; Asimus S; Abuqayyas L; Zhou XH; Scott IC; Cardner M; Parnes JR; et al. (The Journal of allergy and clinical immunology, 2026)